Therapy Selection, DMT Switching Patterns in Patients With MS
Presenting at CMSC 2022, researchers compared switch treatment patterns and therapy selection decisions between DMTs with anti-CD20 mechanism of action.
Sheila Jacobs
Contributing Writer https://www.neurologyadvisor.com
Sheila Jacobs is the president of STJ Editorial Services. For more than 25 years, Sheila has been providing writing, fact-checking, and editorial services to numerous clients in the medical education, promotional, and managed care arenas, from the conceptual stage through completion of the final editorial product. Her focus has been in a diverse array of therapeutic areas.
